OSN
Single drops of bimatoprost and travoprost appear to provide comparable control of circadian IOP in patients with glaucoma or ocular hypertension when applied while lying in bed or sitting, a small, 36-hour clinical study found.
"This marks the first time a single drop has been used for this type of evaluation," the study authors said.